This page shows the latest LOE news and features for those working in and with pharma, biotech and healthcare.
Customers, the national and regional pharmacy chains and supermarkets, are all keen to work with pharmaceutical companies that own significant LOE brands. ... External expertise. Products that are soon to be off patent must have a clear and effective
More from news
Approximately 0 fully matching, plus 1 partially matching documents found.
It's expected that HCPs will increasingly go to other channels for long-established and LoE products, where product awareness is already high.
For Nycomed this meant loss of exclusivity (LOE) on its blockbuster gastroinestinal drug pantoprazole and the consequent need to reorganise its business.
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Loss of exclusivity (LOE) is a natural milestone in a drug’s lifecycle. ... mind, just as we do for launch – LOE should be strategically planned for years in advance and carefully managed.
For many years, Pharma have reduced the impact of loss of exclusivity (LOE) by launching alternative molecules to treat the same condition. ... However, with the impact of LOE fast approaching, it was vital that they widen their view to consider other
Claire Taylor, Senior Associate Consultant at Blue Latitude Health explains why you should be strategically planning your LOE strategy years in advance.
More from PMHub
Approximately 1 fully matching, plus 2 partially matching documents found.
We're a leading healthcare strategic communications agency helping pharmaceutical companies adapt fast to improve the lives of patients and healthcare...